dapagliflozin/olmesartan medoxomil (ATB-101)
/ Autotelic, Jeil
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 17, 2022
Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes
(clinicaltrials.gov)
- P3 | N=248 | Recruiting | Sponsor: Autotelicbio | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiovascular • Diabetes • Hypertension • Metabolic Disorders • Type 2 Diabetes Mellitus
October 11, 2022
Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes
(clinicaltrials.gov)
- P3 | N=248 | Not yet recruiting | Sponsor: Autotelicbio
New P3 trial • Cardiovascular • Diabetes • Hypertension • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 2
Of
2
Go to page
1